101 related articles for article (PubMed ID: 24000826)
1. Enzyme-dependent lysine deprotonation in EZH2 catalysis.
Kipp DR; Quinn CM; Fortin PD
Biochemistry; 2013 Oct; 52(39):6866-78. PubMed ID: 24000826
[TBL] [Abstract][Full Text] [Related]
2. Convergent evolution of chromatin modification by structurally distinct enzymes: comparative enzymology of histone H3 Lys²⁷ methylation by human polycomb repressive complex 2 and vSET.
Swalm BM; Hallenbeck KK; Majer CR; Jin L; Scott MP; Moyer MP; Copeland RA; Wigle TJ
Biochem J; 2013 Jul; 453(2):241-7. PubMed ID: 23679895
[TBL] [Abstract][Full Text] [Related]
3. A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylation.
Ott HM; Graves AP; Pappalardi MB; Huddleston M; Halsey WS; Hughes AM; Groy A; Dul E; Jiang Y; Bai Y; Annan R; Verma SK; Knight SD; Kruger RG; Dhanak D; Schwartz B; Tummino PJ; Creasy CL; McCabe MT
Mol Cancer Ther; 2014 Dec; 13(12):3062-73. PubMed ID: 25253781
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of histone methylation catalyzed by protein lysine methyltransferase SET7/9 and origin of product specificity.
Guo HB; Guo H
Proc Natl Acad Sci U S A; 2007 May; 104(21):8797-802. PubMed ID: 17517655
[TBL] [Abstract][Full Text] [Related]
5. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas.
Sneeringer CJ; Scott MP; Kuntz KW; Knutson SK; Pollock RM; Richon VM; Copeland RA
Proc Natl Acad Sci U S A; 2010 Dec; 107(49):20980-5. PubMed ID: 21078963
[TBL] [Abstract][Full Text] [Related]
6. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
[TBL] [Abstract][Full Text] [Related]
7. The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states.
Wigle TJ; Knutson SK; Jin L; Kuntz KW; Pollock RM; Richon VM; Copeland RA; Scott MP
FEBS Lett; 2011 Oct; 585(19):3011-4. PubMed ID: 21856302
[TBL] [Abstract][Full Text] [Related]
8. Reaction coupling between wild-type and disease-associated mutant EZH2.
Swalm BM; Knutson SK; Warholic NM; Jin L; Kuntz KW; Keilhack H; Smith JJ; Pollock RM; Moyer MP; Scott MP; Copeland RA; Wigle TJ
ACS Chem Biol; 2014 Nov; 9(11):2459-64. PubMed ID: 25154026
[TBL] [Abstract][Full Text] [Related]
9. Structure of the catalytic domain of EZH2 reveals conformational plasticity in cofactor and substrate binding sites and explains oncogenic mutations.
Wu H; Zeng H; Dong A; Li F; He H; Senisterra G; Seitova A; Duan S; Brown PJ; Vedadi M; Arrowsmith CH; Schapira M
PLoS One; 2013; 8(12):e83737. PubMed ID: 24367611
[TBL] [Abstract][Full Text] [Related]
10. Computational characterization of substrate and product specificities, and functionality of S-adenosylmethionine binding pocket in histone lysine methyltransferases from Arabidopsis, rice and maize.
Satish M; Nivya MA; Abhishek S; Nakarakanti NK; Shivani D; Vani MV; Rajakumara E
Proteins; 2018 Jan; 86(1):21-34. PubMed ID: 29024026
[TBL] [Abstract][Full Text] [Related]
11. Structural context of disease-associated mutations and putative mechanism of autoinhibition revealed by X-ray crystallographic analysis of the EZH2-SET domain.
Antonysamy S; Condon B; Druzina Z; Bonanno JB; Gheyi T; Zhang F; MacEwan I; Zhang A; Ashok S; Rodgers L; Russell M; Gately Luz J
PLoS One; 2013; 8(12):e84147. PubMed ID: 24367637
[TBL] [Abstract][Full Text] [Related]
12. Structural insights of the specificity and catalysis of a viral histone H3 lysine 27 methyltransferase.
Qian C; Wang X; Manzur K; Sachchidanand ; Farooq A; Zeng L; Wang R; Zhou MM
J Mol Biol; 2006 May; 359(1):86-96. PubMed ID: 16603186
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of reagents and assays for EZH2 peptide and nucleosome high-throughput screens.
Diaz E; Machutta CA; Chen S; Jiang Y; Nixon C; Hofmann G; Key D; Sweitzer S; Patel M; Wu Z; Creasy CL; Kruger RG; LaFrance L; Verma SK; Pappalardi MB; Le B; Van Aller GS; McCabe MT; Tummino PJ; Pope AJ; Thrall SH; Schwartz B; Brandt M
J Biomol Screen; 2012 Dec; 17(10):1279-92. PubMed ID: 22904200
[TBL] [Abstract][Full Text] [Related]
14. Chemical mechanism of a cysteine protease, cathepsin C, as revealed by integration of both steady-state and pre-steady-state solvent kinetic isotope effects.
Schneck JL; Villa JP; McDevitt P; McQueney MS; Thrall SH; Meek TD
Biochemistry; 2008 Aug; 47(33):8697-710. PubMed ID: 18656960
[TBL] [Abstract][Full Text] [Related]
15. Lys300 plays a major role in the catalytic mechanism of maize polyamine oxidase.
Polticelli F; Basran J; Faso C; Cona A; Minervini G; Angelini R; Federico R; Scrutton NS; Tavladoraki P
Biochemistry; 2005 Dec; 44(49):16108-20. PubMed ID: 16331971
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2.
Jiao L; Liu X
Science; 2015 Oct; 350(6258):aac4383. PubMed ID: 26472914
[TBL] [Abstract][Full Text] [Related]
17. A687V EZH2 is a gain-of-function mutation found in lymphoma patients.
Majer CR; Jin L; Scott MP; Knutson SK; Kuntz KW; Keilhack H; Smith JJ; Moyer MP; Richon VM; Copeland RA; Wigle TJ
FEBS Lett; 2012 Sep; 586(19):3448-51. PubMed ID: 22850114
[TBL] [Abstract][Full Text] [Related]
18. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis.
Berg T; Thoene S; Yap D; Wee T; Schoeler N; Rosten P; Lim E; Bilenky M; Mungall AJ; Oellerich T; Lee S; Lai CK; Umlandt P; Salmi A; Chang H; Yue L; Lai D; Cheng SW; Morin RD; Hirst M; Serve H; Marra MA; Morin GB; Gascoyne RD; Aparicio SA; Humphries RK
Blood; 2014 Jun; 123(25):3914-24. PubMed ID: 24802772
[TBL] [Abstract][Full Text] [Related]
19. EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation.
Bradley WD; Arora S; Busby J; Balasubramanian S; Gehling VS; Nasveschuk CG; Vaswani RG; Yuan CC; Hatton C; Zhao F; Williamson KE; Iyer P; Méndez J; Campbell R; Cantone N; Garapaty-Rao S; Audia JE; Cook AS; Dakin LA; Albrecht BK; Harmange JC; Daniels DL; Cummings RT; Bryant BM; Normant E; Trojer P
Chem Biol; 2014 Nov; 21(11):1463-75. PubMed ID: 25457180
[TBL] [Abstract][Full Text] [Related]
20. Role of lysine 240 in the mechanism of yeast pyruvate kinase catalysis.
Bollenbach TJ; Mesecar AD; Nowak T
Biochemistry; 1999 Jul; 38(28):9137-45. PubMed ID: 10413488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
